|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
12 December 2020 |
|
Main ID: |
NCT02858713 |
|
Date of registration:
|
03/08/2016 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Adherence in Topical Treatment of Psoriasis
|
|
Scientific title:
|
Can an App Supporting Psoriasis Patients Improve Adherence to Topical Treatment? A Single-blind Randomized Controlled Trial |
|
Date of first enrolment:
|
January 9, 2017 |
|
Target sample size:
|
134 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT02858713 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Supportive Care. Masking: Single (Participant).
|
|
Phase:
|
Phase 4
|
|
|
Countries of recruitment
|
|
Denmark
| | | | | | | |
|
Contacts
|
|
Name:
|
Mathias Tiedemann Svendsen, MD, PhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Department of Dermatology and Allergy Centre, Odense University Hospital |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Psoriasis patients aged 18-75 years with mild-moderate psoriasis. It is mandatory that
patients have a smartphone and basic skills for use of the smartphone.
Exclusion Criteria:
- aged under 18 and above 75 years, guttate psoriasis, severe degree of psoriasis, i.e.
pustular and erythrodermic psoriasis, lack of smartphone and user skills for the
smartphone
Age minimum:
18 Years
Age maximum:
75 Years
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Adherence
|
|
Intervention(s)
|
|
Drug: Calcipotriene + Betamethasone Dipropionate
|
|
Device: App
|
|
Primary Outcome(s)
|
|
Percentage of Adherent Participants
[Time Frame: Week 4]
|
|
Secondary Outcome(s)
|
|
Dermatology Life Quality Index (DLQI)
[Time Frame: Baseline, week 4, 8 and 26]
|
|
Lattice-System Physician's Global Assessment (LS-PGA)
[Time Frame: Week 4, 8 and 26]
|
|
Secondary ID(s)
|
|
2016-002143-42
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|